Treatment for Obesity

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Stanford University, Stanford, CA
Obesity+5 More
Eligibility
< 18
All Sexes
What conditions do you have?
Select

Study Summary

The Stanford Kids CAMP study aims to evaluate the feasibility of enrolling minority participants in school age children (5-13 years old) in a community summer camp setting along with the efficiency by which each participant's biologic specimens are collected. Using remote monitoring technologies and through partnering with community-based organizations, the investigators hypothesize that an increase in underrepresented minority participation in a clinical trial that is greater than the national average is possible.

Eligible Conditions

  • Obesity
  • Pre-diabetes
  • Diabetes Mellitus

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 7 Secondary · Reporting Duration: Baseline (prior to arrival at camp)

Baseline (prior to arrival at camp)
Percentage of underrepresented minority participants enrolled
Day 1
Continuous patient monitoring performance
Day 1
Physical activity measured by accelerometry
Day 1
Duration of initial participant screening
Day 1
Number of patient reported device related issues
Day 1
At-home urine specimen collection
Day 6
Report of issues and concerns during at-home monitoring period
Day 14
Participant perceived use of study technology

Trial Safety

Safety Progress

1 of 3

Trial Design

0 Treatment Group

100 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline (prior to arrival at camp)
Closest Location: Stanford University · Stanford, CA
Photo of Stanford University 1Photo of Stanford University 2Photo of Stanford University 3
1992First Recorded Clinical Trial
14 TrialsResearching Obesity
774 CompletedClinical Trials

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,130 Previous Clinical Trials
35,668,810 Total Patients Enrolled
63 Trials studying Obesity
117,006 Patients Enrolled for Obesity
Karl Sylvester, MDPrincipal InvestigatorStanford University

Eligibility Criteria

Age < 18 · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
Avoid use of acetaminophen-containing medications while wearing the CGMS.
You are willing to wear a continuous glucose sensor and physiological monitor for the duration of the study.
A parent/caregiver is available for system training and will commit to be the main responsible person for the use of the monitoring system at home.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.